What is the GPT Healthcare PE ratio today?
GPT Healthcare's PE ratio is 23.8 at the 29 October 2026 close (₹136.89 a share): a market capitalisation of ₹1,123 crore divided by consolidated net profit of ₹47.3 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹42.2 crore) it is 26.6.
What is the GPT Healthcare debt to equity ratio?
GPT Healthcare's debt-to-equity ratio was 0.06 on 31 March 2026: borrowings of ₹16.1 crore against total equity of ₹269 crore. A year earlier, on 31 March 2025, it was 0.05.
What is the GPT Healthcare net worth?
GPT Healthcare's net worth — shareholders' equity in its consolidated balance sheet — was ₹269 crore on 31 March 2026, up 8.7% from ₹248 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,123 crore at the 29 October 2026 close.
What is the GPT Healthcare PB ratio (price to book value)?
GPT Healthcare's price-to-book (PB) ratio is 4.17 at the 29 October 2026 close: a market capitalisation of ₹1,123 crore divided by shareholders' equity (book value) of ₹269 crore on 31 March 2026. That is a book value of ₹32.84 per share against a share price of ₹136.89.
What is the GPT Healthcare ROE and ROCE?
In FY26, GPT Healthcare's return on equity (ROE) was 16.3% and its return on capital employed (ROCE) was 16.4%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 21.4% and ROCE 22.2%.
What is the GPT Healthcare book value per share?
GPT Healthcare's book value per share was ₹32.84 on 31 March 2026: shareholders' equity of ₹269 crore divided by the 8.21 crore shares in issue, up 8.7% from ₹30.21 a year earlier. The share price at the 29 October 2026 close was ₹136.89.
What is the GPT Healthcare market cap?
GPT Healthcare's market capitalisation was ₹1,123 crore at the 29 October 2026 close: 8.21 crore shares at ₹136.89 each.
What is the GPT Healthcare EPS?
GPT Healthcare's basic earnings per share (EPS) were ₹5.15 in FY26, against ₹6.08 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹5.76.
What is the GPT Healthcare dividend in 2026 and its record date?
In 2026, GPT Healthcare has declared one dividend: ₹1.50 with record date 30 July 2026.
Is GPT Healthcare debt free?
No. GPT Healthcare had borrowings of ₹16.1 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.06. Its cash and current investments were ₹47.4 crore, so it held net cash of ₹31.3 crore.
What is the GPT Healthcare dividend yield?
GPT Healthcare's dividend yield is 1.83% at the 29 October 2026 close: dividends of ₹2.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹136.89. They were ₹1.50 on 30 July 2026 and ₹1 on 14 November 2025 (interim).
What is the GPT Healthcare promoter holding?
Promoters held 65.57% of GPT Healthcare on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
What is the GPT Healthcare shareholding pattern?
On 30 September 2026, GPT Healthcare's shares were held by promoters 65.57%, foreign portfolio investors (FII/FPI) 3.00%, domestic institutions (DII) 7.10% (including mutual funds at 4.61%) and retail and other non-institutional investors 24.32%. Over the year, FII holding was down 0.20 percentage points from 3.20% and DII holding was up 0.64 percentage points from 6.46%.
What are the GPT Healthcare latest quarterly results?
GPT Healthcare's latest results are for Q1 FY27 (April–June 2026), filed on 3 August 2026: consolidated net profit ₹12.7 crore, up 65.7% from ₹7.7 crore in Q1 FY26; revenue from operations ₹126 crore, up 17.8% year on year.
How does the GPT Healthcare PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit, GPT Healthcare's PE ratio is 26.6, the third highest of the four: Gujarat Kidney And Super Speciality 87.4, Shalby 35.1 and Indraprastha Medical Corporation 15.9, a peer average of 46.1. Each is the company's market capitalisation at that price divided by its FY26 net profit.
What is the GPT Healthcare free cash flow?
In FY26, GPT Healthcare generated ₹81.2 crore of cash from operations and spent ₹41.8 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹39.3 crore. In FY25 it was ₹17.5 crore.
What is the GPT Healthcare revenue and profit in FY26?
In FY26 (April 2025–March 2026), GPT Healthcare's consolidated net profit was ₹42.2 crore, down 15.4% from ₹49.9 crore in FY25, on revenue from operations of ₹473 crore (up 16.1%).
When are the GPT Healthcare next results?
GPT Healthcare will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, the date of the board meeting it has notified to the exchanges.
How does GPT Healthcare compare with its peers?
On FY26 consolidated figures, against Gujarat Kidney And Super Speciality, Shalby and Indraprastha Medical Corporation: GPT Healthcare's operating margin of 12.1% is the third highest of the four (Gujarat Kidney And Super Speciality 27.1%, Shalby 6.4%, Indraprastha Medical Corporation 15.1%; peer average 16.2%); its return on equity of 16.3% is the second highest of the four (Gujarat Kidney And Super Speciality 6.1%, Shalby 3.7%, Indraprastha Medical Corporation 27.5%; peer average 12.4%).
GPT Healthcare vs Gujarat Kidney And Super Speciality: how do they compare?
In FY26, GPT Healthcare earned net profit of ₹42.2 crore on revenue of ₹473 crore, against ₹15.5 crore on ₹82 crore for Gujarat Kidney And Super Speciality. GPT Healthcare's operating margin was 12.1% (Gujarat Kidney And Super Speciality 27.1%) and its return on equity 16.3% (Gujarat Kidney And Super Speciality 6.1%). At the 29 October 2026 close, GPT Healthcare's market capitalisation was ₹1,123 crore against ₹1,355 crore for Gujarat Kidney And Super Speciality, and its PE ratio on FY26 profit 26.6 against 87.4.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
